Rubedo Life Sciences

📍 Sunnyvale, United States🗓 Founded 2018👥 33 employees💰 Last funded Oct 2024
Biotechnology🌐 rubedolife.com
Website LinkedIn
Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. Our proprietary ALEMBIC™ drug discovery platform has engineered novel first-in-class small molecules designed to selectively target senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic and other chronic disorders. The Rubedo leadership team is composed of industry leaders and pioneers in chemistry, technology, and the life sciences, with a deep bench of expertise in drug development and commercialization spanning from large pharma to biotech innovators. The company is based in Sunnyvale, CA.
3
Total investors
0
Early stage
0
Mid stage
3
Late stage
2018
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Italy
1
Frequently asked questions
Who invested in Rubedo Life Sciences?
Rubedo Life Sciences has 3 investors on record on gritt.io and 3 late-stage investors.
When did Rubedo Life Sciences last raise funding?
The most recent investment in Rubedo Life Sciences recorded on gritt.io was in October 2024.
When was Rubedo Life Sciences founded?
Rubedo Life Sciences was founded in 2018.
What industry is Rubedo Life Sciences in?
Rubedo Life Sciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Rubedo Life Sciences based?
Rubedo Life Sciences is headquartered in Sunnyvale, United States.